• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泡沫硬化疗法中 1:2 聚多卡醇与 1:4 空气比例治疗下肢网状静脉的安全性和疗效比较。

Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.

机构信息

Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.

Westlake Dermatology & Cosmetic Surgery, Dallas, Texas.

出版信息

Dermatol Surg. 2020 Dec;46(12):1715-1720. doi: 10.1097/DSS.0000000000002709.

DOI:10.1097/DSS.0000000000002709
PMID:32947299
Abstract

BACKGROUND

Foam sclerotherapy is a common treatment of lower extremity reticular veins. The effect of different liquid-gas ratios on foam stability and efficacy has been controversial.

OBJECTIVE

To evaluate the use of 2 different polidocanol (POL) to air ratios for the treatment of reticular veins of the lower extremities.

METHODS AND MATERIALS

Patients with lower extremity reticular veins were randomized to foam sclerotherapy with POL mixed with 4 mL of room air for one lower extremity or 2 mL for the other lower extremity. All telangiectasias were treated with glycerin immediately after treatment of the reticular veins. Adverse events (AEs) and efficacy were evaluated by both subject and blinded investigator.

RESULTS

Thirty subjects completed the study. No statistically significant difference was seen in AEs between the 2 different POL to air ratios by subject questionnaire and blinded investigator scores at all time points. Subjects and blinded investigator reported a mean improvement between 0% and 50% at Day 21 and 26% to 75% at Day 90, which was not significantly different between groups.

CONCLUSION

Two different POL to air ratios, 1:2 versus 1:4, were similarly safe and efficacious for the treatment reticular veins of the lower extremities.

摘要

背景

泡沫硬化疗法是治疗下肢网状静脉的常用方法。不同液气比的泡沫稳定性和疗效一直存在争议。

目的

评估 2 种不同的聚多卡醇(POL)与空气的比例用于治疗下肢网状静脉。

方法和材料

下肢网状静脉患者随机分为泡沫硬化疗法,一侧下肢用 POL 混合 4 毫升空气,另一侧下肢用 2 毫升空气。所有毛细血管扩张症在治疗网状静脉后立即用甘油治疗。不良事件(AEs)和疗效由患者和盲法研究者评估。

结果

30 名患者完成了研究。在所有时间点,通过患者问卷和盲法研究者评分,两种不同的 POL 与空气比例之间的不良事件无统计学差异。患者和盲法研究者报告在第 21 天和第 90 天分别有 0%至 50%和 26%至 75%的平均改善,组间无显著差异。

结论

对于治疗下肢网状静脉,1:2 与 1:4 两种不同的 POL 与空气比例同样安全有效。

相似文献

1
Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.泡沫硬化疗法中 1:2 聚多卡醇与 1:4 空气比例治疗下肢网状静脉的安全性和疗效比较。
Dermatol Surg. 2020 Dec;46(12):1715-1720. doi: 10.1097/DSS.0000000000002709.
2
Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.下肢网状静脉硬化治疗的三盲随机临床试验。
JAMA Dermatol. 2017 Dec 1;153(12):1249-1255. doi: 10.1001/jamadermatol.2017.3426.
3
A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.一种新型硬化剂复合制剂:聚桂醇-平阳霉素泡沫。
Dermatol Surg. 2020 Dec;46(12):1712-1714. doi: 10.1097/DSS.0000000000002533.
4
Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).毛细血管扩张症和网状静脉的硬化治疗:聚多卡醇、十四烷基硫酸钠和等渗盐水的双盲、随机、对比临床试验(EASI研究)。
Phlebology. 2010 Jun;25(3):124-31. doi: 10.1258/phleb.2009.009043.
5
Sclerotherapy: a study comparing polidocanol in foam and liquid form.硬化疗法:一项比较聚多卡醇泡沫剂和液体剂型的研究。
Phlebology. 2010 Feb;25(1):44-9. doi: 10.1258/phleb.2009.008064.
6
A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of a High-Potency Topical Corticosteroid After Sclerotherapy for Reticular and Telangiectatic Veins of the Lower Extremities.一项关于高效局部用皮质类固醇在下肢网状和毛细血管扩张性静脉硬化治疗后效果的随机、双盲、安慰剂对照研究。
Dermatol Surg. 2015 Oct;41(10):1158-63. doi: 10.1097/DSS.0000000000000467.
7
A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.静脉曲张学中硬化泡沫稳定性的研究综述。
Dermatol Surg. 2020 Feb;46(2):249-257. doi: 10.1097/DSS.0000000000002039.
8
A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.冷冻激光冷冻硬化疗法与硬化疗法治疗毛细血管扩张和网状静脉的对比研究:一项随机对照试验。
J Vasc Surg Venous Lymphat Disord. 2024 Jul;12(4):101874. doi: 10.1016/j.jvsv.2024.101874. Epub 2024 Mar 24.
9
Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.聚多卡醇与高渗葡萄糖用于下肢网状静脉硬化治疗:一项随机对照试验的研究方案
Trials. 2014 Dec 19;15:497. doi: 10.1186/1745-6215-15-497.
10
Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.聚多卡醇硬化治疗后的皮肤色素沉着:一项系统评价。
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):274-283. doi: 10.1111/jdv.18639. Epub 2022 Oct 17.

引用本文的文献

1
Treatment for telangiectasias and reticular veins.毛细血管扩张和网状静脉的治疗。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD012723. doi: 10.1002/14651858.CD012723.pub2.